Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

EMA CHMP gives positive opinion on ZS-9 for hyperkalemia

Feb. 27, 2017

Reata initiates phase II/III study of bardoxolone methyl to treat Alport syndrome-associated CKD

Feb. 24, 2017

Revive Therapeutics and InMed in term sheet agreement for cannabinoid therapies for kidney diseases

Feb. 23, 2017

Lanthio Pharma initiates first-in-human trial of MOR-107

Feb. 22, 2017

Astellas Pharma describes novel MC4 receptor agonists

Feb. 17, 2017

Ardelyx's phase III trial of tenapanor meets primary endpoint

Feb. 15, 2017

Ionis Pharmaceuticals earns milestone from Bayer for advancing antisense drugs

Feb. 15, 2017

Anti-VEGF-B agent CSL-346 developed to treat diabetic kidney disease

Feb. 14, 2017

First patient dosed in Angion Biomedica's phase II study of BB3

Feb. 1, 2017

Lundbeck discovers novel PDE9 inhibitors

Jan. 26, 2017

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 22, 2026.
Alicorn synthesizes new AAK1 inhibitors
BioWorld Science
Researchers from Alicorn Pharmaceutical Co. Ltd. and Jiangsu Alicorn Pharmaceutical Co. Ltd. have disclosed crystalline salts of compounds acting as...
CFTX-2034 successfully shows promise for post-bariatric hypoglycemia in preclinical research
BioWorld Science
Researchers from Confo Therapeutics NV presented the preclinical characterization of CFTX-2034, a selective somatostatin receptor subtype 5 (SSTR5) agonist...
Saniona reports preclinical data for SAN-2668
BioWorld Science
Saniona AB has presented preclinical data and its clinical development strategy for its lead clinical candidate, SAN-2668, which is a GABA-A receptor positive...
CC-3 antibody shows antitumoral activity in penile cancer
BioWorld Science
Advanced penile cancer (PeCa) is a rare cancer affecting the genitourinary tract with a 5-year survival rate of about 10% when metastatic. First-line therapies...